The clearance expands access to the LigaSure vessel-sealing technology within robotic surgical workflows.
|Articles|September 3, 2014
Erectile dysfunction: Multiple treatment options
This video presents a thorough description of all the treatment options available for erectile dysfunction, including their administration, benefits, and limitations.
Advertisement
In this video, I present a thorough description of all the treatment options available for erectile dysfunction, including their administration, benefits, and limitations.
James M. Hotaling, MD, MS, Section Editor
Dr. Hotaling is assistant professor of surgery (urology) at the
More 'Y'tube videos
Advertisement
Related to this article
A phase 1 study found topical sildenafil cream was linked with lower systemic exposure than oral sildenafil and was well tolerated in healthy men.
In this episode, Karen Bigman, MBA, joins to discuss sexual health, intimacy, and relationship challenges facing adults as they navigate midlife and beyond.
One year following the approval of the gemcitabine intravesical system, Joseph Jacob, MD, reflects on the expanding treatment landscape in BCG-unresponsive NMIBC.
A limited market release of SpaceOAR Flex is expected to begin in the US later this year.
The PDUFA target action date is in the fourth quarter of 2026.
The approval is supported by data from the phase 3 LITESPARK-011 trial.
Pearls & Perspectives: Expanding Sexual Health Conversations Through Digital Media, With Wendy Brant
Amy Pearlman, MD, and Wendy Brant discuss building a digital audience, navigating sexual health content online, and the role of communication in relationships.
Advertisement
Advertisement
Trending on Urology Times
1
The Evolving Landscape of Minimally Invasive BPH Therapy
2
TURP, HoLEP, and the Future of Minimally Invasive BPH Therapy
3
FDA grants 510(k) clearance to SpaceOAR Flex Hydrogel for prostate radiotherapy
4
One year of Inlexzo: Evolving care in BCG-unresponsive NMIBC
5